Komori
Yorozu (7294) · PolicyRestated

Use of retained earnings for R&D, capital investment and strategic investments

First written in FY2017-Q1. 6 of 7 entries say "Restated". Latest entry: FY2018-Q3.

7entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2018-Q32016: 220162017: 420172018: 12018
Same theme, other companies
Reinvestment in R&D, capital expenditures and M&AA theme 71 companies write about · 0 as a headwind · 71 as a tailwind

The whole theme swung hardest in 2025: 3 of 37 companies on the "Worse" side.

23 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 71 companies compared. The sentences above are computed from all 71.
Full recordFilings, disclosures and news, newest first
  1. FY2018-Q3RestatedAnnual report

    「Meanwhile, the policy is to allocate retained earnings to research and development expenses, capital investment, strategic investment and other areas as funds necessary to increase corporate value in the future.」

    The Company has reaffirmed its policy of allocating retained earnings to research and development, capital investment and strategic investment.
  2. FY2018-Q2RestatedAnnual report

    「Meanwhile, the policy is to allocate retained earnings to research and development expenses, capital investment, strategic investment and other areas as funds necessary to increase corporate value in the future.」

    The Company has reiterated its policy of allocating retained earnings to research and development, capital investment and strategic investment.
  3. FY2018-Q1RestatedAnnual report

    「Meanwhile, the policy is to allocate retained earnings to research and development expenses, capital investment, strategic investment and other areas as funds necessary to increase corporate value in the future.」

    The Company has reiterated its policy of allocating retained earnings to research and development, capital investment and strategic investment.
  4. FY2017RestatedAnnual report

    「The policy is to allocate retained earnings to research and development expenses, capital investment, strategic investment and other areas as funds necessary to increase corporate value in the future.」

    The Company has reaffirmed its policy of allocating retained earnings to research and development, capital investment and strategic investment.
  5. FY2017-Q3RestatedAnnual report

    「Meanwhile, the policy is to allocate retained earnings to research and development expenses, capital investment, strategic investment and other areas as funds necessary to increase corporate value in the future.」

    There has been no change to the policy of allocating retained earnings to research and development, capital investment and strategic investment.
  6. FY2017-Q2RestatedAnnual report

    「Meanwhile, the policy is to allocate retained earnings to research and development expenses, capital investment, strategic investment and other areas as funds necessary to increase corporate value in the future.」

    There has been no change to the policy of allocating retained earnings to research and development, capital investment and strategic investment.
  7. FY2017-Q1First statedAnnual report

    「The policy is to allocate retained earnings to research and development expenses, capital investment, strategic investment and other areas as funds necessary to increase corporate value in the future.」

    The Company has stated a policy of allocating retained earnings to investments necessary to increase corporate value in the future.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Yorozu yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.